Attached here with order updates recieved on 28.10.2026

Date: 29th October, 2026 BSE Limited, Floor 25, P J Towers, Dalal Street, Mumbai – 400001 Scrip ID: SHELTER Scrip Code: 543963 Subject: Intimation titled “Shelter Pharma Limited secures export orders worth Rs. 3,46,94,820.52 (Rupees Three Crore Forty-Six Lacs Ninety-Four Thousand Eight Hundred and Twenty rupees only and Fifty-Two paise) Dear Sir/Madam, Pursuant to Regulation 30 read with schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith the intimation titled “Shelter Pharma Limited secures export orders worth Rs. 3,46,94,820.51 (Rupees Three Crore Forty-Six Lacs Ninety-Four Thousand Eight Hundred and Twenty rupees only and Fifty-Two paise)”. The details pursuant to SEBI Listing Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 is mentioned in the Annexure A. Kindly take the above information on record. Thanking You, FOR SHELTER PHARMA LIMITED MUSTAQIM NISARAHMED SABUGAR MANAGING DIRECTOR DIN: 01456841 Annexure – A Details pursuant to Regulation 30 of SEBI Listing Regulations, 2015 and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January, 2026 Sr. Particulars Details 1 Name of the Taha Drugs & First Vet Veterinary Genet International entity Chemicals Co. Medicines Trading awarding the Ltd. L.L.C order 2 Significant The Company has The Company has The Company has terms and received purchase received purchase received purchase conditions of orders for supply orders for supply of orders for supply of order of Nutraceutical Animal feed Animal feed awarded in products namely: Supplements Supplements brief namely: namely:  Joemega Capsules  Electrolyte  IMMUNO UP Qty (box) Dex C Qty (box) 3,60,000 x 2000pcs x 2000 x 0.88 0.80 – (USD 9.50 – (USD – (USD 1,760) 2,88,000) 19,000)  IMMUNO UP  Foliman  Lactocal Gel Qty (box) Tablet Qty Super 3000 x 0.40 (box) 2000pcs x – (USD 1,200) 2,00,000 x 0.85 – (USD  NGK FORTE 0.12 – (USD 1,700) Qty (box) 24,000)  Livodin-12 2000 x 0.70  All Vitamin Liquid – (USD Tablet Qty 2000pcs x 1,400)  BUTA-B (box) 1.30 – (USD BOLUS Qty 34,500 x 2,600) (box) 3000 x 0.55 – (USD 1.90 – (USD 18,975) 5,700) 3 Whether International International Entity International Entity order have Entity been awarded by domestic/ international entity 4 Nature of Normal course of Normal course of Normal course of order; business business business 5 Whether International International International domestic or international 6 Time period The order is to be The order is to be The order is to be by which the executed within executed within the executed within the order is to be the mutually mutually agreed mutually agreed executed agreed timelines timelines as per timelines as per as per purchase purchase order purchase order order schedule. schedule. schedule. 7 Broad USD 3,30,975 or USD 23,300 or Rs. USD 10,060 or Rs. consideration Rs. 22,18,807.74 9,57,991.67 or size of the 3,15,18,021.11 (Rupees Twenty Two (Rupees Nine lacs order (Rupees Three lacs Eighteen Fifty Seven Crore Fifteen Thousand Eight Thousand Nine Lakhs Eighteen hundred and Seven hundred and Thousand and rupees and Seventy Ninety One rupees Twenty One Four Paise only) and Sixty Seven Rupees and Paise only) Eleven Paise only) 8 Whether the No, the promoter No, the promoter / No, the promoter / promoter/ / promoter group promoter group / promoter group / promoter / group group companies do group companies group / companies do not not have any do not have any group have any interest interest in the interest in the companies in the entity. entity. entity. have any interest in the entity that awarded the order? If yes, nature of interest and details thereof 9 Whether the No, the No, the transaction No, the transaction order would transaction does does not fall under does not fall under fall within not fall under related party related party related party related party transactions. transactions. transactions? transactions. Shelter Pharma Limited Secures Export Orders Worth USD 3,64,335 We are delighted to announce our Stakeholders and Exchange that the Company has received export orders aggregating USD 3,64,335 from well-established customers, reflecting the continued trust placed in our capabilities by leading institutions as mentioned below: 1. Order from Taha Drugs & Chemicals Co. Ltd. - USD 3,30,975 The Company has received an order of $3,30,975 from Taha Drugs & Chemicals Co. Ltd. it includes $ 2,88,00 towards Joemega Capsules, $24,000 towards Foliman Tablet, $18,975 towards All Vitamin Tablet. 2. Order from First Vet Veterinary Medicines Trading L.L.C – USD 23,300 The Company has received an order of $23,300 from First Vet Veterinary Medicines Trading L.L.C it includes $19,000 towards Electrolyte Dex C, $1,700 towards Lactocal Gel Super, $2,600 towards Livodin-12 Liquid. 3. Order from Genet International – USD 10,060 The Company has received an order of $10,060 from Genet International it includes $1,760 towards IMMUNO UP, $1,200 towards IMMUNO UP, $1,400 towards NGK FORTE, $5,700 towards BUTA-B BOLUS. Market Size of Nutraceuticals and Animal Feed Nutraceuticals  Global: Valued at US$ 454.5 billion in 2025, projected to reach US$ 1,021.7 billion by 2034 (CAGR 9.5%).  Middle East & Africa: Holds a 3.7% global share in 2025 and is expected to grow at 9.8% CAGR (2025–2034), driven by a young population, government-backed nutrition programs, and rising incomes in the GCC.  India: The India nutraceuticals market size was estimated at USD 38.77 billion in 2025 and is projected to reach USD 84.99 billion by 2033, growing at a CAGR of 10.3% from 2026 to 2033. A primary driver for market growth is the escalating health awareness among Indian consumers, particularly post-pandemic, leading to a proactive approach to well-being rather than reactive treatment. Animal Feed  Global: Valued at US$ 502.4 billion in 2025, projected to reach US$ 748.6 billion by 2034 (CAGR 4.5%).  India: Valued at INR 1,186.30 billion in 2025, expected to reach INR 2,112.96 billion by 2034 (CAGR 6.6%).  Middle East & Africa: Accounts for 4.9% of global revenue in 2025. (Sources: Data Intelo – Nutraceuticals Market Outlook 2025–2034; IMARC – Indian Animal Feed Market Size, Share, Trends and Forecast, 2026–2034 Grand view Research - India Nutraceuticals Market 2026 - 2033)